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Abstract
The endocrine-secreting lobe of the pituitary gland, or adenohypophysis, forms from cells at the anterior margin of the neural plate
through inductive interactions involving secreted morphogens of the Hedgehog (Hh), fibroblast growth factor (FGF), and bone morphogenetic protein (BMP) families. To better understand when and where Hh signaling influences pituitary development, we have analyzed the
effects of blocking Hh signaling both pharmacologically (cyclopamine treatments) and genetically (zebrafish Hh pathway mutants). While
current models state that Shh signaling from the oral ectoderm patterns the pituitary after placode induction, our data suggest that Shh plays
a direct early role in both pituitary induction and patterning, and that early Hh signals comes from adjacent neural ectoderm. We report that
Hh signaling is necessary between 10 and 15 h of development for induction of the zebrafish adenohypophysis, a time when shh is expressed
only in neural tissue. We show that the Hh responsive genes ptc1 and nk2.2 are expressed in preplacodal cells at the anterior margin of the
neural tube at this time, indicating that these cells are directly receiving Hh signals. Later (15–20 h) cyclopamine treatments disrupt anterior
expression of nk2.2 and Prolactin, showing that early functional patterning requires Hh signals. Consistent with a direct role for Hh signaling
in pituitary induction and patterning, overexpression of Shh results in expanded adenohypophyseal expression of lim3, expansion of nk2.2
into the posterior adenohypophysis, and an increase in Prolactin- and Somatolactin-secreting cells. We also use the zebrafish Hh pathway
mutants to document the range of pituitary defects that occur when different elements of the Hh signaling pathway are mutated. These
defects, ranging from a complete loss of the adenohypophysis (smu/smo and yot/gli2 mutants) to more subtle patterning defects (dtr/gli1
mutants), may correlate to human Hh signaling mutant phenotypes seen in Holoprosencephaly and other congenital disorders. Our results
reveal multiple and distinct roles for Hh signaling in the formation of the vertebrate pituitary gland, and suggest that Hh signaling from
neural ectoderm is necessary for induction and functional patterning of the vertebrate pituitary gland.
© 2003 Elsevier Science (USA). All rights reserved.
Keywords: Adenohypophysis; Placode; Gli; Smoothened; Sonic hedgehog; Somatolactin; Prolactin; Cyclopamine

Introduction
The vertebrate pituitary gland forms as a cranial placode
through inductive interactions between two types of ectodermal tissues: head epidermis (classically called Rathke’s
pouch in mammals) and neural ectoderm of the ventral
diencephalon. As a result of these interactions, two pituitary
lobes form: epidermal tissue in the developing placode
thickens to form the anterior lobe or adenohypophysis,
while neural tissue grows ventrally to form the posterior
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lobe or neurohypophysis. Each of these two tissue types
requires interactions with the other in order to form the
appropriate pituitary structures (Baker and Bronner-Fraser,
2001; Dasen and Rosenfeld, 2001).
The origin of the pituitary placode now appears to be
similar in all vertebrates examined. Historically, morphological studies in mammals pointed to epidermis of Rathke’s pouch as the source of the adenohypophysis. However,
fate mapping data from mouse (Osumi-Yamashita et al.,
1994), rat (Kouki et al., 2001), chick (Couly and Le Douarin, 1985), and frogs (Eagleson et al., 1986; Knouff, 1935)
indicate that Rathke’s pouch/adenohypophyseal cells are
derived from ectodermal cells at the anterior margin of the
neural plate (reviewed in Baker and Bronner-Fraser, 2001;
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Rubenstein et al., 1998). Similarly, marker analysis and fate
mapping in zebrafish suggest that the teleost adenohypophysis also originates at the anterior margin of the neural tube.
More specifically, medial cells at the anterior margin of the
zebrafish neural tube give rise to the pituitary placode, while
more lateral/posterior cells give rise to the adjacent olfactory placodes (Whitlock and Westerfield, 2000).
Cell– cell signaling via the Hedgehog (Hh) signaling
system has recently been shown to be required for adenohypophysis formation. Analyses of mice which lack Sonic
Hedgehog (Shh) signaling only in developing adenohypophyseal cells show that Hh signaling is directly required
for patterning and proliferation of cells in Rathke’s pouch
(Treier et al., 2001). Additionally, ectopic Shh leads to the
expansion of ventral pituitary cell types in mice (Treier et
al., 2001). Genetic approaches in zebrafish complement
analyses in mice and have revealed a conserved role for Hh
in teleost pituitary development. Mutations that severely
block hedgehog signaling either at the level of the Hh
receptor complex smoothened [the slow-muscle-omitted
(smu) mutation] (Chen et al., 2001; Varga et al., 2001) or at
the level of the Hh responsive transcription factor Gli2 [the
you-too (yot) mutation] (Karlstrom et al., 1999) completely
block formation of the adenohypophysis. In these mutants,
an ectopic midline lens forms in place of the pituitary,
suggesting transdifferentiation of placodal cells (Kondoh et
al., 2000; Varga et al., 2001). Other identified zebrafish
hedgehog pathway mutants include sonic-you (syu), which
encodes Shh (Schauerte et al., 1998), and detour (dtr),
which encodes zebrafish Gli1 (Karlstrom et al., in press).
Based on shared phenotypes, chameleon (con) and iguana
(igu) are also likely to affect some aspect of Hh signaling
(Brand et al., 1996; Karlstrom et al., 1996; Odenthal et al.,
2000; van Eeden et al., 1996). Together, these zebrafish
mutants provide a unique tool for dissecting the roles played
by different components of the Hh signaling system in
adenohypophysis development.
Shh is clearly not the only important signaling molecule
in the forming adenohypophysis. Other cell signaling molecules needed for pituitary development include members
of the fibroblast growth factor (FGF) and bone morphogenetic protein (BMP) families (reviewed in Scully and
Rosenfeld, 2002). Loss of BMP4 in mouse embryogenesis
arrests early pituitary development and prevents the emergence of specific cell lineages (Takuma et al., 1998; Treier
et al., 1998). FGF signaling is also needed early in pituitary
induction and subsequently for differentiation of dorsal cell
types (Ericson et al., 1998; Takuma et al., 1998; Treier et
al., 1998). In current models, it is proposed that Shh from
ventral epidermal tissue induces a ventrodorsal gradient of
BMP2 in oral ectoderm, which then acts to oppose dorsal
FGF signals (Scully and Rosenfeld, 2002; Treier et al.,
2001). These signaling interactions result in the activation
of a large number of pituitary-specific transcription factors
that include the lim homeodomain transcription factors
Lhx3 and Lhx4 (reviewed in Dasen and Rosenfeld, 2001).

Lhx3 (lim3 in zebrafish) and Lhx4 are expressed in the
developing adenohypophysis of mouse embryos, and mice
lacking either of these genes have severe defects in adenohypophyseal induction and cell differentiation (Sheng et al.,
1997). In zebrafish, lim3 is expressed in the developing
pituitary from early ages (Glasgow et al., 1997).
While previous genetic studies have shown that Hh signaling is directly needed for cell proliferation and patterning
within the adenohypophysis (Treier et al., 2001), the source
and timing of Hh signals is not well established. Published
models suggest that epidermis adjacent to Rathke’s pouch is
the source of Hh signals in mammals (e.g., Scully and
Rosenfeld, 2002; Treier et al., 2001). Since Shh is expressed
at earlier times in neural tissue adjacent to the anterior
neural ridge (Treier et al., 1998), and since fate mapping data
show that this region is the source of Rathke’s pouch (OsumiYamashita et al., 1994), it is equally likely that earlier neural
expression plays a direct role in pituitary induction.
Understanding how and when Hh helps form the vertebrate pituitary is particularly important because defects in
Hh signaling are implicated in a large number of human
congenital disorders that result in hypopituitarism (Parks et
al., 1999). These disorders include holoprosencephaly
(HPE) and Pallister–Hall syndrome, which result in a large
range of malformations from the complete loss of the pituitary gland to more subtle pituitary reductions and mislocations (Kang et al., 1997; Muenke and Cohen, 2000; Stevenson et al., 1993).
In this paper, we examine the temporal and spatial requirement for Hh signaling in zebrafish pituitary development. We show that Hh is needed during at least three stages
for pituitary gland formation and that early Hh signals must
originate from adjacent neural ectoderm. A careful analysis
of the zebrafish Hh pathway mutants shows a range of
pituitary phenotypes that result from mutations in different
Hh pathway components. These combined genetic and experimental analyses of adenohypophysis development in
zebrafish promise to shed light on human pituitary defects
caused by mutations in different components of the Hh
signaling system.

Materials and methods
Wild-type and mutant fish lines
Wild-type and mutant zebrafish are maintained at the
University of Massachusetts-Amherst Fish Facility as described (Westerfield, 1993). Embryos were grown at 28.5°C
and staged as described (Kimmel et al., 1995). Alleles used
were you-too, yotty17 (Karlstrom et al., 1996, 1999) detour,
dtrts269 (Karlstrom et al., 1996), sonic you, syutbx392
(Schauerte et al., 1998), slow-muscle-omitted, smub641 (Barresi et al., 2000; Varga et al., 2001), iguana, iguts294 (Brand
et al., 1996; Karlstrom et al., 1996), and chameleon, conth6
(Brand et al., 1996; Karlstrom et al., 1996).
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In situ hybridization and antibody labeling
In situ labeling was performed as described (Karlstrom et
al., 1999). Probes used were dlx3 (Akimenko et al., 1994),
eyaB (same as eya1; Sahly et al., 1999), fgf8 (Furthauer et
al., 1997), isl1 (Inoue et al., 1994), lim3 (Glasgow et al.,
1997), nk2.2 (Barth and Wilson, 1995), ptc-1 (Concordet et
al., 1996), shh (Krauss et al., 1993), and twhh (Ekker et al.,
1995). Anti-sense digoxigenin-labeled probes were synthesized with the Dig RNA Labeling Kit (Sp6/T7) from Roche.
Antibody labeling was performed as described (Karlstrom et al., 1996). Briefly, embryos were fixed in 4%
paraformaldehyde for either 2 h at room temperature or
overnight at 4°C and, then dehydrated in MeOH. After
rehydration, embryos were blocked for 1 h and incubated in
polyclonal antibodies anti-PRL (1:2000) or anti-SL
(1:2000) (generous gift of H. Kawauchi; Kawauchi et al.,
1983; Rand-Weaver et al., 1992). For fluorescent labeling,
embryos were incubated in Rhodamine-conjugated goat
anti-rabbit antibody (1:1000; Sigma). For peroxidase labeling, embryos were incubated in goat anti-rabbit biotin (1:
200; Jackson) followed by avidin–HRP (1:500; Sigma).
Peroxidase labeling was visualized with diaminobenzidine
(DAB; Sigma). DAB-labeling reactions were stopped by
incubation in 4% paraformaldehyde overnight. Embryos were
cleared in 75% glycerol and examined by using DIC optics.
Cyclopamine treatments
Embryos were treated with 50 or 100 M cyclopamine
(gift from W. Gaffield, then purchased from Toronto Chemical) (Incardona et al., 1998) by adding 5 or 10 L of 10
mM stock solution (in 95% EtOH) to 1 ml of egg water (0.3
g/L Instant Ocean Salt, 1 mg/L Methylene Blue) starting at
the time points indicated. At early time points (up to 24 h),
no difference was seen between 50 and 100 M treatments.
After the 24-h stage, treatment with 50 M cyclopamine
gave variable results, so 100 M was used for older embryos. Control embryos were treated simultaneously with an
equal volume (10 L) of 95% EtOH (cyclopamine carrier)
in 1 ml egg water. Treatments were carried out in 12-well
plates in 1 mL egg water (n ⫽ 30 embryos/well) at 28.5°C.
Embryos were dechorionated in egg water by using 0.2
mg/ml (final) pronase (Sigma) at 37°C and fixed at 21, 30,
36, or 48 h with 4% paraformaldehyde, dehydrated in
MeOH, then processed for in situ hybridization and antibody labeling.
RNA injections
Capped shh and GFP RNA were made by in vitro transcription using T7 polymerase (mMessage Machine; Ambion). The shh/T7TS plasmid was linearized with BamHI,
the twhh/T7TS plasmid was linearized with HindIII (Ekker
et al., 1995) and our GFP/T7TS plasmid was linearized with
XbaI. RNA was diluted in 1⫻ “dani-eau” solution [58 mM
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NaCl, 0.7 mM KCl, 0.4 mM MgSO4, 0.6 mM Ca(NO3)2, 5
mM Hepes, phenol red]. Embryos were injected through the
chorion with approximately 100 pg RNA at the one- to
two-cell stage by using a pressure injector, grown in egg
water at 28.5°C, fixed at 30 h, and processed for in situ
hybridization or antibody labeling.

Results
Functional regionalization in the early zebrafish
adenohypophysis
To better understand the early formation and patterning
of the zebrafish adenohypophysis, we first examined expression of the known pituitary marker lim3 (Glasgow et al.,
1997) in relation to the homeobox transcription factor nk2.2,
which is expressed in the adenohypophysis and is positively
regulated by Hh signals (Barth and Wilson, 1995; Karlstrom
et al., 1999; Varga et al., 2001). As previously reported
(Glasgow et al., 1997), lim3 (Lhx3 in mouse) is expressed
throughout the visibly thickened placode at 36 h of development (Fig. 1A). In contrast, we found that nk2.2 is expressed only in the anterior region of the adenohypophyseal
placode (Fig 1B), uncovering previously unreported regional patterning within the placode that might be related to
Hh signaling. To determine whether this regionalization of
early gene expression is correlated with functional organization of the adenohypophysis, we examined the onset of
hormone expression in the placode. We found that antibodies generated against the salmon pituitary hormones Somatolactin (SL) and Prolactin (PRL) (Kawauchi et al., 1983;
Rand-Weaver et al., 1992) label the developing zebrafish
adenohypophysis as early as 30 h of development. SLsecreting cells are present throughout the adenohypophysis,
similar to the expression domain of lim3 (compare Fig. 1A,
C, and E), while PRL-secreting cells are located anteriorly
in the region that expresses nk2.2 (Fig. 1B, D, and F). The
restricted expression of nk2.2 and PRL indicates that cells in
the developing adenohypophysis are not equivalent and that
Hh signaling may play a role in this functional patterning of
the zebrafish pituitary.
Hh signaling directs pituitary development in three
distinct phases
Previous studies have shown that Hh signaling is necessary for pituitary development (Karlstrom et al., 1999;
Kondoh et al., 2000; Treier et al., 2001). To directly test
when Hh signaling is needed for adenohypophyseal induction and patterning, we assayed the effects of pharmacologically blocking Hh signaling at various developmental
stages. Pituitary gene expression was assayed in embryos
treated with the plant steroidal alkaloid, cyclopamine, that
blocks Hh signaling at the level of the smoothened receptor
complex protein (Taipale et al., 2000).

Fig. 1. Regionalization of the early adenohypophysis. (A) lim3 is expressed in the entire adenohypophyseal placode. (B) nk2.2 is expressed in the anterior region (arrowhead)
of the placode. (C, E) Somatolactin (SL)-secreting cells are present throughout the adenohypophysis at 30 h (arrowheads). (D, F) Prolactin (PRL)-secreting cells are present
only in the anterior region of the adenohypophysis at 30 h (arrowhead). (A–D) Lateral views, eyes removed, anterior to the left. (E, F) Ventral views, anterior up. Brackets
show anterior/posterior extent of the morphologically visible placode. te, telencephalon; di, diencephalon; dot shows position of optic recess.
Fig. 2. Timed inhibition of Hh signaling with cyclopamine. Initiation and duration of cyclopamine treatment is indicated by black bars with images showing appropriately
staged embryos (images from Karlstrom and Kane, 1996). Embryos in (A–J) were fixed and labeled at 30 h. (A) Treatments starting at 5 or 10 h result in the loss of a visible
adenohypophyseal placode and loss of all lim3 expression at 30 h. These embryos often develop an ectopic lens in place of an adenohypophysis (arrowhead in A). (B)
Treatment at 15 h severely reduces lim3 expression in a thin but visible placode. (C, D) Embryos treated starting at 20 or 24 h have smaller adenohypophyses with reduced
lim3 expression. (E) Control embryos treated with an equal volume of EtOH (cyclopamine carrier) have normal adenohypophyses that express lim3. (F, G) Cyclopamine
treatments starting at 5, 10, or 15 h eliminate nk2.2 expression and PRL cells (inset in G) at 30 h. (H) Treatment at 20 h eliminates nk2.2 expression and severely reduces
PRL cell numbers (inset). (I) Cyclopamine treatment starting at 24 h reduces nk2.2 expression in the anterior adenohypophysis (arrow). (J) Normal nk2.2 and PRL labeling
in EtOH-treated control embryos. (K) Cyclopamine treatments at 5 or 10 h eliminate lim3 expression at 21 h. (M) dlx3 expression at 21 h is not affected by early cyclopamine
treatments. (L, N) lim3 and dlx3 expression in EtOH-treated controls. (O, Q) Cyclopamine treatment starting at 30 h reduces nk2.2 expression at 36 h relative to controls
(arrowheads). (P, R) Embryos treated from 36–48 hours have nk2.2 expression similar to that seen in control treated embryos (compare arrowheads). (A–J) and (O–R) show
lateral views, anterior to the left, eyes removed; (K–N) show dorsal/anterior views, anterior up. Cyo, cyclopamine.
Fig. 3. ptc1 and nk2.2 expression precedes lim3 expression in preplacodal cells at the anterior margin of the neural tube. (A) Schematic of the zebrafish forebrain during
somitogenesis, dorsal view, anterior up. Based on expression of lim3 and fate mapping experiments, the pituitary placode arises from medially located cells (purple) at the
anterior edge of the neural tube (Glasgow et al., 1997; Whitlock and Westerfield, 2000). Asterisks show where the pituitary transcription factors lim3 and nk2.2 are first
expressed. (B) At the 8-somite (S) stage, the early placodal marker dlx3 labels marginal cells spanning the midline of the neural tube and more lateral cells that coalesce to
form the olfactory placodes (arrows). (C) At 17 S, dlx3 is expressed by a thinner band of preplacodal cells at the anterior margin. (D) The Hh receptor ptc1 is expressed in
neural tissue and in anterior marginal cells (arrowheads) at 14 S. Inset shows lateral view. (E) shh expression is restricted to neural tissue, no expression is seen in epidermal
cells (arrowheads). Inset shows lateral view. (F) nk2.2 expression begins anterior to the neural tube as early as 14 S and is often seen only on the left side (arrowhead). (G)
By 16 S, nk2.2 is expressed anterior to the neural tube on both sides of the embryo (arrowheads). (H, I) Between 19 and 23 S, nk2.2 expression expands across the midline
in anterior marginal cells (arrowheads). (J) At 14 S, no lim3 expression is detectable in anterior marginal cells (arrowhead). (K) lim3 expression is first detectable at
approximately 17 S (arrowhead). (L, M) Between 20 and 23 S, lim3 expression expands across the midline (arrowheads). All panels show dorsal/anterior views of the anterior
edge of the nervous system, anterior up. Insets in (D) and (E) show lateral views, anterior to the left. Dotted lines on left side of embryo show position of the visible border
between neural tissue and epidermal cells at the anterior margin of the nervous system. This border was established by careful examination of magnified images and multiple
labeled embryos.
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Fig. 4. Regionalization within the developing adenohypophysis. (A–D) Expression of shh and twhh (insets) is restricted to the neural tube; no expression is
seen in anterior epidermal cells (arrowhead in A). (E–H) ptc1 expression extends into nonneural cells at the anterior edge of the embryo, anterior to the shh
expression domain (arrowheads). (I, J) nk2.2 is expressed anterior to the neural tube at 18 h (arrowhead), and this expression is distinct from the neural
expression domain (arrow in inset). (K, L) At 24 and 30 h, nk2.2 is expressed in the anterior region of the visibly thickened adenohypophyseal placode
(arrowheads) with expression restricted to the anterior region at both ages (arrowheads in insets). (M, N) lim3 expression anterior to the neural tube at 18
and 19 h (arrowhead). (O, P) lim3 continues to be expressed in the entire thickened placodal region at 24 and 30 h (arrowheads). (Q–T) The placodal marker
eyaB is expressed throughout the adenohypophyseal placode (arrowheads). All panels show lateral views, eyes removed, anterior to the left. Insets show
parasagittal sections. te, telencephalon; di, diencephalon; dot shows position of optic recess.

Pre-somitogenesis: Hh signaling is required for pituitary
induction
Incubation in cyclopamine starting prior to the onset of
somitogenesis (5, 8, or 10 h) completely blocks adenohypophyseal development (Table 1), similar to the phenotype
seen in the most severe Hh signaling mutants smu/smo
(Varga et al., 2001) and yot/gli2 (Karlstrom et al., 1999)
(see below). Following these early treatments, no placode is
visible at 30 h, and both lim3 and nk2.2 expression are
completely absent in the epidermis ventral to the hypothalamus (Fig. 2A and F). Embryos treated before 10 h also
often develop an ectopic lens in place of the adenohypoph-

ysis (Fig. 2A), as is seen in smu/smo, yot/gli2, and igu
mutants (Kondoh et al., 2000; Varga et al., 2001). The lack
of a pituitary in embryos treated with cyclopamine starting
at 10 h shows that, while earlier Hh signaling may play a
role in pituitary induction, it is not sufficient to induce lim3
expression in the absence of later Hh signaling.
These results show that early Hh signaling is required for
pituitary development but do not reveal whether this requirement is specific for induction of pituitary placode cells,
or whether the loss of pituitary structures is due to a general
loss of preplacodal cells at the anterior margin of the neural
tube. To test for a pituitary specific role for Hh signaling and
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determine whether competent placodal cells are present, we
examined the expression of the anterior neural ridge marker
dlx3 in embryos treated with cyclopamine at early time
points. Embryos were treated at 5 or 10 h of development,
fixed at 21 h (23 S), and processed to determine dlx3 and
lim3 expression. Early treatment with cyclopamine had no
effect on dlx3 expression at the anterior margin (Fig. 2M).
This suggests that anterior marginal cells are present at early
stages and that these cells can express markers appropriate for cranial placode development. In contrast, early
cyclopamine treatments result in a loss of lim3 expression in
the same region (Fig. 2K), indicating that adenohypophysis
development is specifically disrupted.
Since current models suggest that Hh signals originate
from invaginated oral epidermis, we examined early pituitary-specific gene expression in relation to the invagination
at the anterior end of the embryo that might correspond to
the formation of oral ectoderm. At the times when cyclopamine blocks pituitary formation, we see no anterior invagination of oral ectoderm (see Fig. 4 below). In fact, lim3
continues to be expressed superficially, ventral to the diencephalon, through 36 h of development (see Fig. 1). Thus,
early Hh-dependent events are occurring prior to the invagination of oral ectoderm.

Fig. 5. Ectopic shh expands lim3 and nk2.2 expression and induces PRL
and SL cell populations. (A, B) lim3 expression in GFP mRNA-injected
(A) and shh mRNA-injected (B) embryos. shh mRNA injections lead to
posterior expansion of the lim3 expression domain (arrow in B). (C, D)
nk2.2 expression in GFP mRNA-injected (C) and shh mRNA-injected (D)
embryos. nk2.2 expression is expanded within the developing placode
(compare arrows in C and D). (E–H) PRL cell populations in GFP (E, G)
and shh (F, H) mRNA-injected embryos. The number of PRL-producing
cells is consistently expanded in the anterior region of the adenohypophysis. (I) SL-producing cells are present throughout the adenohypophysis
(bracket) in control (GFP) RNA-injected embryos. (J) Ectopic SL cells
(arrows) are induced after shh mRNA injection. All panels show 30-h
embryos that were injected with 100 pg of the indicated mRNA at the twoto four-cell stage. (A, B, E, F, I, J) Ventral views, anterior up. (C, D, G, H)
Lateral views, eyes removed, anterior to the left. Brackets show anterior/
posterior extent of adenohypophysis. di, diencephalon.

Late somitogenesis stages: Hh signaling patterns the
pituitary
To test for later Hh roles in adenohypophysis development, we next used cyclopamine to block Hh signaling at
later time points. Treatment starting at 15 h (12 S) and 20 h
(21 S) leads to more subtle defects in the early pituitary
placode. Treatment starting at 15 h (12 S) eliminates nk2.2
expression while severely reducing lim3 expression (Fig.
2B and G; Table 1). PRL cells are either eliminated (Fig.
2G, inset), or a few (1– 6) cells are seen (Table 2). Treatment starting at 20 h eliminates nk2.2 expression, but PRLproducing cells are present and lim3 is expressed in a
morphologically visible adenohypophysis (Fig. 2C and H;
Tables 1 and 2). Blocking Hh signaling at these stages
selectively blocks anterior gene expression, suggesting that
Hh signaling is necessary for anterior cell fates. This indicates that Hh signaling may help pattern the pituitary along
the anterior/posterior axis.
Post somitogenesis: Hh signaling maintains anterior
pituitary gene expression
Cyclopamine treatments starting at 24 h lead to slightly
reduced adenohypophyseal placodes with extremely reduced nk2.2 expression at 30 h (Fig. 2D and I; Table 1).
Since nk2.2 is strongly expressed at 24 h (see Fig. 4K
below), we conclude that Hh signaling is needed to maintain
this expression after 24 h. Cyclopamine effects become
weaker after 30 h. About one-third of the embryos treated at
30 h and examined at 36 h have adenohypophyses that
appear normal morphologically but have moderately reduced nk2.2 expression (Fig. 2O), while about two-thirds of
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Table 1
Effect of cyclopamine treatment on gene expression in the adenohypophysis
Cyclopamine treatment
(stage started)

5–30 h (pregastrulation)
8–30 h (80% epiboly)
10–30 h (1 somite)
15–30 h (12 somites)
20–30 h (21 somites)
24–30 h (prim 5)
30–36 h (prim 15)
36–48 h (prim 22)
EtOH (all experiments)

Embryos with
no adenohypophyses

Embryos with
reduced adenohypophysis

Unaffected
embryos

no lim3

no nk2.2

s lim3

no nk2.2

s nk2.2

wt lim3

wt nk2.2

91/91 (100%)
80/80 (100%)
55/55 (100%)
0
0
0
n.d.
n.d.
0

102/102 (100%)
60/60 (100%)
78/78 (100%)
0
0
0
0
0
0

0
0
0
31/31 (100%)
43/43 (100%)
108/108 (100%)
n.d.
n.d.
0

0
0
0
67/67 (100%)
51/51 (100%)
0
0
0
0

0
0
0
0
0
159/159 (100%)
11/34 (32%)
4/24 (17%)
0

0
0
0
0
0
0
n.d.
n.d.
406/406 (100%)

0
0
0
0
0
0
23/34 (68%)
20/24 (83%)
417/417 (100%)

s, reduced expression; n.d., no data.

the embryos treated at this time point have wild-type levels
of nk2.2 expression (Table 1). This suggests that 30 h may
be a transitional time point when Hh signaling is no longer
required for maintenance of nk2.2 expression in the anterior
adenohypophysis. To test this, we treated embryos starting
at 36 h and assayed lim3 and nk2.2 expression at 48 h. We
observed no differences between treated embryos and controls (Fig. 2P and R), confirming that Hh signaling is not
needed to maintain anterior gene expression at these later
time points.
Hh response in the early pituitary placode
Our cyclopamine experiments indicate that Hh signaling
is necessary for pituitary formation between 10 and 20 h of
development but do not illuminate whether this role is direct
or indirect. Since ptc1 expression is directly regulated by Hh
signals and is commonly used to indicate a direct cellular
response to Hh signals (see Goodrich and Scott, 1998;
Ingham and McMahon, 2001), we examined ptc1 expression at the anterior margin of the embryo between 15 and
20 h of development. Consistent with a direct requirement
for Hh signaling in early pituitary induction, ptc1 is expressed in preplacodal cells anterior to the visible border of
the neural tube as early as 16 h (Fig. 3D). Similar anterior
ptc1 expression was seen in mouse (Treier et al., 2001). To

Table 2
Effect of cyclopamine treatment on PRL secreting cells
Cyclopamine
treatment

Embryos
with
no PRL cells

15–30 h (12
8/22 (36%)
somites)
20–30 h (21
0
somites)
EtOH (all
0
experiments)

Embryos with
1–6 PRL cells

Embryos with
9–15 PRL cells (wt)

14/22 (64%)

0

10/20 (50%)

10/20 (50%)

0

30/30 (100%)

confirm that this expression is in preplacodal cells, we
compared ptc1 expression with that of the preplacodal
marker dlx3 (Whitlock and Westerfield, 2000). Similar to
ptc1, dlx3 is expressed anterior to this same visible border
(Fig. 3B and C). Also consistent with our cyclopamine
results, shh and the closely related molecule twhh are expressed at this age in the forebrain. In contrast to ptc1,
expression of shh (Fig. 3E) and twhh (data not shown) is
restricted to the adjacent neural tube. This indicates that
neural tissue adjacent to the forming placode must be the
source of Hh signals.
To understand how this early Hh signaling relates to
pituitary gene expression, we next examined pituitary expression of nk2.2 and lim3. Like ptc1, nk2.2 expression is
known to depend on Hh signaling (Barth and Wilson, 1995;
Karlstrom et al., 1999; Varga et al., 2001). nk2.2 expression
begins in cells anterior to the neural tube by 15–16 h (12–14
S) on the left side of the embryo (Fig. 3F) and is present on
both sides of the midline by 17 h (16 S; Fig. 3G). Expression of the more definitive pituitary marker lim3 also begins
on the left side of the neural plate (Glasgow et al., 1997;
data not shown) but is not detectable in these cells until
approximately 17.5 h (17 S; Fig. 3J and K), 1–2 h after
nk2.2 expression begins and slightly earlier than previously
reported (Glasgow et al., 1997). By 19 h (19 –20 S), nk2.2
and lim3 are both expressed at comparable levels in cells
anterior to the neural tube (Fig. 3H and L). By 20.5 h (23 S),
both nk2.2 and lim3 expression span the midline anterior to
the neural tube (Fig. 3I and M).
To summarize, expression of the Hh responsive genes
ptc1 and nk2.2 at the anterior margin of the neural tube
indicates that these preplacodal cells are directly responding
to Hh signals at a time when disruption of Hh signaling
eliminates pituitary formation. At the same time, expression
of shh and twhh is restricted to adjacent neural ectoderm,
suggesting that the diencephalon is the source of these Hh
signals. This Hh response precedes the expression of the
pituitary-specific transcription factor lim3 by 1–2 h.

J.L. Sbrogna et al. / Developmental Biology 254 (2003) 19 –35

27

Table 3
shh mRNA injections
Injected mRNA

Embryos with
a lim3

Embryos with
a nk2.2

Embryos with
a PRL

Embryos with
a SL

50 pg shh
100 pg shh
500 pg shh
100 pg GEP

n.d.
65/75 (87%)
25/25 (100%)
0/40

0/57
83/94 (88%)
43/43 (100%)
0/75

n.d.
14/14 (100%)
n.d.
0/50

n.d.
27/34 (79%)
n.d.
0/16

a, ⱖ50% increase in area of gene expression (lim3, nk2.2) or cell number (PRL, prolactin; SL, somatolactin); n.d., no data.

Hh signaling and patterning of the adenohypophysis
Our cyclopamine experiments indicate that Hh signaling
between 20 and 25 h plays a role in functional patterning of
the adenohypophysis. To learn when the adenohypophysis
first becomes regionally patterned, and to determine whether
Hh signaling might play a direct role in this patterning
event, we examined the expression of shh, twhh, ptc1,
nk2.2, lim3, and the general placodal marker eyaB (same as
eya1, Sahly et al., 1999) in the adenohypophysis as it becomes morphologically distinct at the end of somitogenesis.
At 18 h (18 S), 19 h (20 S), and 24 h, shh and twhh
expression are restricted to neural tissue of the diencephalon
(Fig. 4A–C). In contrast, ptc1 and nk2.2 expression extend
into epidermal cells anterior to the developing forebrain, in
the same region that expresses the pituitary marker lim3 and
the placodal marker eyab (Fig. 4). This shows that epidermal cells in the developing placode are directly responding
to Hh signaling at these ages, and that the source of Hh
signals is most likely the ventral diencephalon. Interestingly, the nk2.2 expression domain is initially broader than
the lim3 expression domain (compare insets in Fig. 4I and
M). However, by 24 h, nk2.2 and ptc1 expression becomes
restricted to the anterior region of the lim3- and eyaBexpressing placode (Fig. 4G, K, O, and S), suggesting that
only anterior cells continue to directly respond to Hh signals. shh and twhh are expressed exclusively in neural tissue
dorsal to the developing adenohypophysis until 30 –36 h,
when expression begins in ectoderm and endoderm ventral
to the diencephalon (not shown; see Fig. 9). Importantly,
ptc1 and nk2.2 expression in the anterior region of the
adenohypophysis indicates that these cells are directly responding to Hh signals at a time when cyclopamine blocks
anterior cell fates.
Overexpression of Shh expands pituitary gene expression
To test whether Shh signaling can directly regulate pituitary cell fates, we ectopically expressed Shh by injecting
shh encoding mRNA at the one- to two-cell stage and
analyzed pituitary lim3, nk2.2, PRL, and SL expression at
30 h. Ectopic shh expression consistently leads to expanded
lim3 expression in epidermis ventral to the forebrain in
close proximity to the normal expression domain (Fig. 5A
and B; Table 3). Ectopic shh also consistently leads to

increased numbers of SL-secreting cells (see Fig. 7I), and
these cells can be found in ectopic locations throughout the
ventral forebrain (Fig. 5J), sometimes as far lateral as the
eye.
In most shh-injected embryos, nk2.2 expression expands
to almost fill the entire, somewhat enlarged, adenohypophyseal placode (Fig. 5C and D; Table 3). PRL-expressing cells
are increased by ectopic shh expression (see Fig. 7I), but
these cells are only found in the anterior region of the
adenohypophysis (Fig. 5E–H; Table 3). Thus, while ectopic
Hh signals can expand nk2.2 throughout the placode, differentiation of PRL cells seems to be confined to anterior
domains, perhaps because of a requirement for another
permissive factor in the anterior region, or alternatively
because of the presence of a posterior repressor. These
experiments show that Shh signaling is capable of inducing
both the expression of pituitary-specific genes and the differentiation of specific populations of hormone-secreting
cells.
Zebrafish Hh pathway mutants display a range of
pituitary defects
Hh signaling mutations lead to a broad range of human
phenotypes, from loss of ventral midline tissue in the forebrain and complete cyclopia to more minor cranial midline
defects (Odent et al., 1999; Roessler and Muenke, 2001).
Since this same range of cranial phenotypes is seen in a
number of zebrafish mutations known to affect Hh signaling (Brand et al., 1996), we examined pituitary development in the zebrafish Hh pathway mutants to determine
how forebrain midline defects correlate with pituitary
deficiencies.
The most severe pituitary phenotype is seen in smu/
smoothened mutant embryos which have no detectable pituitary and generally lack ventral forebrain tissue (Varga et
al., 2001). In smu mutants, pituitary expression of lim3 and
nk2.2 is completely absent (Fig. 6C and D; Table 4; Varga
et al., 2001), no Prolactin- and Somatolactin-secreting cells
develop (Fig. 7), and an ectopic lens forms in the region of
the adenohypophysis (Fig. 6D; Varga et al., 2001). These
defects are identical to those seen upon early treatments
with cyclopamine (starting at 10 h or before) and therefore
seem to reflect an early and complete block of Hh signaling.
Less severe ventral forebrain deficiencies in igu mutant
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Fig. 6. Pituitary defects in Hh pathway mutants. (A, B) Wild-type pituitary
expression of (A) lim3 and (B) nk2.2 (arrows). (C, D) smu/smo mutant
embryos lack a discernible adenohypophysis and often develop an ectopic
lens (arrowhead in D). lim3 (C) and nk2.2 (D) expression is absent in the
region. (E, F) yot/gli2-DR mutants have severely reduced or absent lim3
expression and no placodal nk2.2 expression (arrow). (G, H) igu mutants
also have reduced or absent lim3 expression and no placodal nk2.2 expression (arrows). (I, J) syu/shh mutants have reduced lim3 expression and no
placodal nk2.2 expression (arrows). (K, L) con and (M, N) dtr/gli1 mutants
both have moderately reduced lim3 expression and reduced nk2.2 expression. Lateral views of ventral head, eyes removed, anterior to the left.
Brackets show anterior/posterior extent of the adenohypophysis when
visible. di, diencephalon.

embryos (Brand et al., 1996) are accompanied by ectopic
midline lenses (Kondoh et al., 2000) and severely reduced
adenohypophyses (Fig. 6G and H; Table 4).

Loss of shh gene function in syu mutants (Schauerte et
al., 1998), or the production of dominant repressor (DR)
forms of the Hh-responsive transcription factor gli2 found
in yot mutants (Karlstrom et al., 1999; Karlstrom et al.,
in press), leads to ventral forebrain deficiencies that are
less severe than those seen in smu and igu, and the eyes in
syu/shh and yot/gli2-DR mutants are well separated (Brand
et al., 1996; Schauerte et al., 1998). Despite these less
severe visible cranial defects, the adenohypophysis is extremely reduced (60 –70% of embryos) or absent (30 – 40%
of embryos) in syu/shh and yot/gli2-DR mutants (Fig. 6;
Table 4). A few hormone-producing cells are present in
most syu/shh embryos (Fig. 7), suggesting that signaling
molecules other than Shh (perhaps Twhh, FGFs, and/or
BMPs) are sufficient to induce some pituitary tissue. Unlike
yot/gli2-DR and the other mutants with severe pituitary
defects, syu mutants do not have ectopic lenses, again suggesting that Twhh (or some other midline signaling molecule) can block lens induction at the midline in the absence
of Shh signals.
The least severe cranial defects are seen in the Hh pathway mutants con (Brand et al., 1996; Karlstrom et al., 1996;
Odenthal et al., 2000; Schauerte et al., 1998; van Eeden et
al., 1996) and dtr/gli1 (Brand et al., 1996; Karlstrom et al.,
in press; Karlstrom et al., 1996; Odenthal et al., 2000),
which have well-separated eyes and no ectopic midline
lenses (Kondoh et al., 2000). con and dtr/gli1 mutants have
morphologically visible adenohypophyses with reduced
lim3 and nk2.2 expression (Fig. 6; Table 4) and reduced SL
and PRL cell populations (Fig. 7). Thus, while the milder
con and dtr/gli1 pituitary phenotypes have no visible cranial
defects, both mutants have significant defects in hormone
cell populations.
To summarize, mutations that affect different components of the Hh signaling pathway affect the developing
adenohypophysis to different degrees (Table 5). Even the
mild ventral forebrain deficiencies seen in yot and igu are
correlated with a near complete loss of adenohypophysis,
while mild forebrain defects seen in con and dtr are correlated with significant reductions in certain hormone cell
populations. Consistent with our nk2.2 and lim3 gene expression analysis, more anteriorly located PRL cells are
generally more affected by Hh signaling defects than are the
more broadly distributed SL cells. This suggests that Hh
signaling defects in humans might lead to specific hormone
deficiencies and that anterior populations might be more
affected than more posterior cell types.
Specificity of pituitary defects in Hh pathway mutants
A critical question remains regarding the specificity of
the pituitary defects seen in the Hh pathway mutants and
cyclopamine treated embryos. Other signals from the ventral forebrain, most notably fgf-8 and bmp4, are clearly
needed for normal pituitary development (Ericson et al.,
1998; Kimura et al., 1996). Thus, the pituitary defects seen
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in Hh pathway mutant embryos could be indirectly due to
ventral forebrain defects that lead to a general loss of signaling molecule expression. We therefore examined cell
differentiation in diencephalic tissue adjacent to the developing pituitary in yot and syu mutants which have ventral
forebrain tissue and well-separated eyes, but lack a pituitary. The secreted factor fgf8, which is expressed in the
anterior forebrain in mice and fish (Reifers et al., 1998;
Shimamura and Rubenstein, 1997), is known to synergize
with Hh signaling during mouse pituitary development
(Treier et al., 2001). In yot/gli2 and syu/shh mutants, fgf8 is
expressed in the appropriate region adjacent and dorsal to
the developing adenohypophysis at 15 and 20 h of development (Fig. 8A–F), the times when we show that Hh
signaling is required for pituitary induction (see Fig. 2). In
addition, the transcription factor isl1, a target of BMP signaling in the adenohypophysis (Takuma et al., 1998) is
expressed in the adjacent diencephalon, and in ectodermal
cells continuous with the developing placode, in both yot/
gli2 and syu/shh mutants (Fig. 8G–L). shh itself (Fig. 8M
and N) is also expressed in this region in both yot/gli2 and
syu/shh mutant embryos, indicating that cells adjacent to the
adenohypophysis have differentiated and can express signaling molecules at these ages. Finally, our previous studies
showed that the transcription factor six3 is also expressed in
the anterior diencephalon in yot mutants at 24 h (Kondoh et
al., 2000), indicating that this region of the brain forms in
these mutants. Thus, while we cannot eliminate the possibility of indirect effects, the normal expression of several
markers adjacent to the adenohypophysis, in combination
with the expression of Hh responsive genes in preplacodal
tissue, strongly argues that Hh signaling plays a direct and
early role in pituitary induction.

Discussion
Our results show that Hh signaling plays an important
role in several aspects of pituitary formation. While Hh is
clearly not the only signaling molecule guiding pituitary
induction, several lines of evidence suggest that Hh signaling directly contributes to pituitary induction and patterning. First, timed cyclopamine-mediated blockage of Hh signaling at early somitogenesis stages eliminates all
adenohypophysis development, while later treatments interfere specifically with anterior gene expression. Second, expression of the Hh target genes ptc1 and nk2.2 indicates that
cells at the anterior margin actively transduce Hh signals at

Fig. 7. Reduction of Prolactin (PRL)- and Somatolactin (SL)-secreting
cells in Hh pathway mutants. (A, B) In wild-type embryos, SL-secreting
cells are present throughout the adenohypophysis, while PRL-secreting
cells are only present anteriorly. (C, D) yot/gli2-DR and (E, F) syu/shh
mutants have severely reduced numbers of SL- and PRL-secreting cells.

(G, H) SL and PRL cells are more moderately reduced in dtr/gli1 mutant
embryos. (I) Bar graph showing average numbers of SL and PRL cells in
all of the mutants examined ⫾ s.d., numbers of embryos indicated by n.
Rightmost bars show numbers of cells present at 30 h following injection
of 100 pg of shh mRNA at the two- to four-cell stage. (A–H) Ventral views
of 48-h embryos. Brackets show anterior/posterior extent of the adenohypophysis in wildtype embryos.
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Table 4
Pituitary marker expression in zebrafish Hh pathway mutants
Mutant

nk2.2
absent

nk2.2
reduced

lim3
absent

lim3
reduced

smu
yot
igu
syu
con
dtr

32/32 (100%)
22/22 (100%)
18/18 (100%)
33/33 (100%)
0
0

0
0
0
0
11/11 (100%)
35/35 (100%)

27/27 (100%)
20/51 (39%)
10/39 (26%)
9/29 (31%)
0
0

0
31 (61%)
29/39 (74%)
20/29 (69%)
9/9 (100%)
20/20 (100%)

these cyclopamine-sensitive time points. Third, normal anterior expression of dlx3 in cyclopamine-treated and Hh
mutant embryos shows that early preplacodal differentiation
is unaffected. Fourth, normal expression of fgf8 and diencephalic markers adjacent to the adenohypophysis in Hh
mutants that lack a pituitary indicates that ventral forebrain
structures are present and appropriately express signaling
molecules. Our gene expression analysis strongly suggests
that early Hh signals emanate from adjacent neural tissue to
induce and pattern the adenohypophysis.
Hh signaling and the origin of the zebrafish
adenohypophysis
Our analysis of pituitary and placodal gene expression
strongly supports an origin for the adenohypophysis at the
anterior margin of the neural tube, consistent with one
zebrafish fate mapping experiment (Whitlock and Westerfield, 2000) and similar to other vertebrates (reviewed in
Baker and Bronner-Fraser, 2001). We found that nk2.2 is
initially expressed unilaterally on the left side of the neural
plate (Fig. 3F) in the same left–anterior region as the pituitary-specific marker lim3 (Glasgow et al., 1997; data not
shown). This early asymmetric expression is consistent with
other asymmetrically expressed molecules (reviewed in
Burdine and Schier, 2000) and may point to an early role for
nodal signaling in the earliest stages of pituitary induction.
The epidermal expression of nk2.2 precedes the expression
of the pituitary marker lim3 by at least 2 h, suggesting a very
early role for Hh signaling in adenohypophysis induction.
At the time that epidermal nk2.2 expression begins, the Hh
receptor ptc1 is expressed at high levels in the same region,

further indicating that these cells are receiving Hh signals.
shh and twhh are expressed only in adjacent diencephalic
cells at this time. These data, combined with zebrafish fate
map data (Whitlock and Westerfield, 2000), support a
model for the origin of the zebrafish adenohypophysis in
which (1) cells at the anterior and lateral margins of the
neural tube first become competent to form placodal structures and then (2) Hh signaling from the diencephalon acts
directly (likely in combination with other signals) to induce
differentiation of medial preplacodal cells as adenohypophysis (Fig. 9).
Mouse experiments employing pituitary-specific expression of the Hh inhibitor Hip have also shown that Hh
signaling plays a direct role in early pituitary induction
(Treier et al., 2001). pitx-1 regulatory elements were used to
drive Hip expression at early stages in preadenohypophyseal cells, preventing Hh signaling only in this tissue. These
mice lack an adenohypophysis, indicating that Hh signaling
is directly needed for adenohypophysis induction. Since
pitx-1 is expressed at the anterior neural tube border very
early in adenohypophyseal development and prior to the
onset of lim3 expression (Lamonerie et al., 1996; Szeto et
al., 1996), these data are consistent with an early and direct
role for Hh signaling in pituitary induction. Despite this,
current models only show a later role for Hh signaling, and
show the source of Hh as oral ectoderm surrounding Rathke’s pouch (Scully and Rosenfeld, 2002; Treier et al., 2001).
The idea that Hh signaling from within oral ectoderm helps
pattern the adenohypophysis may derive from gene expression data showing dynamic Shh expression in oral ectoderm
that becomes excluded from Rathke’s pouch as it invaginates (Treier et al., 1998). Our timed inhibition of Hh

Table 5
Comparison of adenohypophyseal (adeno.) defects in Hh pathway mutants

smu
yot
igu
syu
con
dtr

slow-muscle-omitted
you-too
iguana
sonic you
chameleon
detour

Gene

Ectopic
midline lens

Ant. adeno.
(nk2.2)

Entire adeno.
(lim3)

Prolactin

Somatolactin

smoothened
gli2
unknown
sonic hedgehog
unknown
gli1

yes
yes
yes
no
no
no

Absent
Absent
Absent
Absent
Reduced
Reduced

Absent
Abs./reduced
Abs./reduced
Abs./reduced
Reduced
Reduced

Absent
Abs./reduced
Abs./reduced
Abs./reduced
Reduced
Reduced

Absent
Reduced
Reduced
Reduced
Reduced
Reduced
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signaling in zebrafish indicates that Hh-dependent adenohypophyseal induction occurs very early in development at a
time when shh and twhh are expressed only in neural tissue.
Given the similarity of early shh and ptc expression at the
anterior margin of the neural plate in both mice and zebrafish, these data suggest that, in both species, early Hh
signals from the diencephalon may directly influence pituitary induction at the anterior margin of the neural tube.
Two roles for Hh signaling: midline lens inhibition and
pituitary induction
The fact that an ectopic midline lens is seen in place of
the adenohypophysis in the severe Hh signaling mutants
smu/smo and yot/gli2 suggests that an early role for Hh
signaling is to inhibit midline lens formation in the developing placode (Kondoh et al., 2000; Varga et al., 2001).
This raises the possibility that adenohypophyseal defects
seen in these mutants may result from early misspecification
of midline placodal cells as lens, and that Hh signaling does
not actively induce pituitary differentiation. Our extensive
Hh pathway mutant analysis argues against this model, as
several Hh pathway mutants have pituitary defects in the
absence of a midline lens. Most notably, adenohypophysis
development is severely disrupted in syu/shh mutants, but
no midline lenses have been seen (Fig. 6I and J; Kondoh et
al., 2000). The presence of severe pituitary defects in syu/
shh mutants also indicates that Shh, rather than the closely
related molecule Twhh, is needed for pituitary induction. In
fact, Twhh signals may be sufficient to block midline lens
formation in syu/shh mutants, but are clearly unable to
support normal pituitary development. The milder pituitary
defects seen in dtr/gli1 and con mutants also occur in the
absence of midline lens formation, further supporting an
active role for Hh signaling in the pituitary.
Functional patterning within the early adenohypophysis
Our gene expression analysis suggests that the adenohypophysis is regionally organized from the earliest stages of
its development. By 24 h, nk2.2 and ptc1 expression are
clearly restricted to the anterior portion of the adenohypophysis. This regional expression is maintained through at least
48 h of development. The selective anterior/dorsal activation of the Hh responsive genes ptc1 and nk2.2 is consistent
with a direct role for Hh signaling in this patterning event
(Fig. 4E–L, summarized in Fig. 9). Functional hormonesecreting cells differentiate before 30 h of development,
with PRL-secreting cells located only in the anterior region
and SL-secreting cells located throughout the adenohypophysis (summarized in Fig. 9). The functions of PRL and SL
at such early stages of embryogenesis are unknown, but
these hormones are known to regulate growth and osmotic
balance in older fish and may be performing the same
functions in the early embryo.
Mutant analyses often give a limited picture of gene
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function because later requirements for a gene can be
masked by early, more severe phenotypes. The ability to
block Hh signaling at defined points in embryogenesis allowed us to show that Hh signaling is needed later in
development to establish and maintain regional gene expression in the anterior adenohypophysis. Our mutant analysis is consistent with this patterning role. Both dtr/gli1 and
con pituitary defects are more subtle than those seen in other
Hh pathway mutants and anterior nk2.2 expression appears
to be more affected than lim3 expression.
Shh overexpression studies and mutant analyses in
mouse embryos also point to a role for Hh signaling in
regional cell differentiation in the adenohypophysis. Ectopic Shh expression in Rathke’s pouch in mouse embryos
results in expanded ventral cell types (gonadotropes and
thyrotropes) which are normally positioned close to a source
of Shh in oral ectoderm (Treier et al., 2001). Similarly, our
ectopic expression and zebrafish mutant analyses suggest a
role for Hh signaling in differentiation of dorsal/anterior cell
types (lactotropes and somatotropes) that normally form
adjacent to a source of Hh in the diencephalon. This apparent difference in position of Hh-sensitive cell types (anterior
in teleosts, ventral in mammals) could be explained by the
different topologies of the two developing embryos, or
might be the result of differences in timing of initial hormone cell differentiation. Alternatively, the final position of
terminally differentiated cell types in the zebrafish adenohypophysis may be determined by cell migration that occurs
after the period of Hh signaling.
Our shh and ptc1 expression analyses show that cells in
the anterior/dorsal adenohypophysis are closest to the
source of shh in the diencephalon, and thus are likely to be
exposed to the highest concentrations of Shh. Shh has been
shown to act as a classical morphogen in the differentiation
of ventral spinal cord neurons, with distinct neural cell fates
being induced by different concentrations of Shh (Ericson et
al., 1997). We hypothesize that Shh might act similarly as
a morphogen to guide differentiation along the dorsal/
anterior–ventral/posterior axis in the adenohypophysis (Fig.
9). Alternatively, or perhaps in combination, Hh signaling
may function as a mitogen causing proliferation of cells in
the anterior region, a role that has been shown in other
systems (Rowitch et al., 1999). The fact that shh-injected
embryos have, on average, two times the number of PRLproducing cells in the anterior adenohypophysis does not
help answer this question, as increased cell numbers could
be due to induction of more precursor cell types or to the
increased proliferation of the same number of precursor
cells. In addition, the failure of PRL cells to differentiate in
more posterior regions could be because our generalized
overexpression of Shh was insufficient to reach the appropriate threshold level posteriorly, or because additional factors are needed for PRL cell differentiation. We are currently investigating these possibilities.
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Fig. 8. Forebrain marker expression in yot/gli2 and syu/shh mutant embryos. (A) The signaling molecule fgf8 is expressed in the telencephalon and in dorsal
diencephalic cells adjacent to the developing adenohypophysis (bracket) at 15 h of development. (B, C) In yot/gli2 and syu/shh mutants, fgf8 is expressed
normally in cells adjacent to the developing adenohypophysis (arrowheads), suggesting that fgf8 signaling defects do not account for the lack of pituitary
development seen in these mutants. (D–F) At 20 h, fgf8 is still expressed adjacent and dorsal to the adenohypophysis in yot/gli2 and syu/shh mutants
(arrowheads). (G) The transcription factor isl1 is expressed in adjacent diencephalic cells (arrowheads), as well as in epidermal cells (arrows) that are
continuous with and overlap the developing adenohypophysis (bracket) at 15 h of development. (H, I) isl1 is expressed in these same adjacent cells in yot/gli2
and syu/shh mutants (compare arrowheads and arrows). Increased labeling in (H) is due to the presence of additional extraembryonic membrane. (J–L) isl1
is expressed in the diencephalon of both yot/gli2 and syu/shh mutants at 20 h (arrowheads), indicating this diencephalic cell type can differentiate in the
absence of Shh signals. Epidermal isl1 expression is largely absent by 20 h in both wildtype and mutant embryos. (M, N) shh is appropriately expressed
adjacent to the developing adenohypophysis at 15 h in yot/gli2 mutant embryos (arrowheads), showing that this region of the brain is capable of signaling
to adjacent epidermal tissue. In all panels, a black dot shows the position of the optic recess, the anterior border between the telencephalon (te) and
diencephalon (di).

Hh signaling from neural to endocrine tissues
The most thoroughly described role for Hh signaling
during organogenesis is in the establishment of ventral cell
fates within the neural tube (reviewed in Ingham and Mc-

Mahon, 2001). Shh from axial mesoderm of the notochord
directs differentiation of the floor plate and various ventral
neural cell types in the overlying neural tube. As patterning
occurs, shh expression is lost in the notochord and the floor
plate becomes the source of shh (Placzek, 1995). Our results
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Fig. 9. Model summarizing requirements for Hh signaling in early pituitary development. Left diagram shows a dorsal anterior view while other schematics
show lateral views. Phase 1: Hh signaling is required during early somitogenesis to induce the pituitary placode. dlx3 expression at the anterior and lateral
margins of the neural tube is thought to indicate the region competent to form placodal structures and this expression remains in anterior epidermal tissue
at least through the 17-somite stage (17 h). Hh signaling induces nk2.2 and lim3 expression in medial cells at the anterior margin of the neural tube, while
fgf8 is expressed more dorsally in this same anterior region (not shown, see Fig. 8). Phase 2: Hh signaling is required for anterior expression of nk2.2 during
later somitogenesis stages. Anterior margin cells expressing nk2.2 and lim3 are initially adjacent to shh-expressing neural cells and become separated from
the region of shh expression (arrow). fgf8 is expressed in the anterior telencephalon, with expression adjacent to the dorsalmost region of the forming
adenohypophysis. Phase 3: Hh signaling is required to maintain the expression of nk2.2 in the anterior region of the adenohypophysis between 24 and 35 h
of development. By 30 h, Prolactin (PRL)-secreting cells arise within the nk2.2-expressing anterior region, while Somatolactin (SL)-secreting cells are present
throughout the lim3-expressing adenohypophysis. shh is expressed in overlying neural tissue and in endodermal tissue ventral to the adenohypophysis at these
stages. All drawings are tracings of shh-labeled wild-type embryos.

indicate that expression of shh in anterior neural tissue also
induces and patterns adjacent nonneural tissue, the developing epidermal cells in the adenohypophysis. A similar
role for Shh has recently been described in the formation of
pancreatic endocrine cells that arise from a distinct cell type,
the endoderm (diIorio et al., 2002; Roy et al., 2001). Shh
was shown to play multiple roles in pancreas islet cell
development, being necessary both for initial induction and
for proper cell positioning (diIorio et al., 2002). Interestingly, many of the transcription factors that respond to Hh
signaling in neural tissues (nk2.2, pax, and lim genes) are
similarly regulated in the nonneuronal cells of the pituitary
and pancreas as they differentiate in response to Hh signals.
The similar response in these distinct tissues (epidermis,
endoderm, and neural ectoderm) suggests that Hh signaling
helps convey positional information (distance from the
source of Hh) to diverse endocrine precursor cells.
Zebrafish Hh mutants as a model for human
holoprosencephaly
There is a broad spectrum of developmental phenotypes
associated with mutations that disrupt Hh signaling in humans. Holoprosencephaly (HPE) is a major human congenital disorder and approximately 17% of human familial HPE

is associated with SHH mutations (Muenke and Cohen,
2000). HPE phenotypes range from the most severe, including cyclopia and loss of the pituitary gland, to less severe
forms that include closely spaced eyes, a single midline
incisor, and hypopituitarism (Cameron et al., 1999; Johnson, 1989; Kjaer and Fischer-Hansen, 1995). In these less
severe cases, pituitary deficiencies lead to decreased levels
of Adrenocorticotropin (ACTH) or Growth Hormone (GH)
(Cameron et al., 1999; Rappaport et al., 1977), which result
in adrenal hypoplasia and short stature, respectively. Our
panel of zebrafish Hh signaling mutants carry mutations in
different components of the Shh pathway and have a range
of pituitary phenotypes (see Figs. 6 and 7; Table 5) that may
correlate to reported human pituitary defects, including specific hormone deficiencies (Cameron et al., 1999; Rappaport
et al., 1977). In particular, our analysis shows that mutations
in the Gli transcription factors may form the molecular basis
of subtle forms of HPE that would be associated with
specific pituitary patterning defects. Continued analysis of
the zebrafish Hh pathway mutants thus promises to help
explain how milder, nonlethal mutations in Hh signaling
can lead to subtle pituitary defects that might have profound
consequences for human development. The genetic and
experimental accessibility of the zebrafish thus make it a
powerful model system to better understand the molecular
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nature of HPE and other disorders affecting pituitary development in humans.
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